Position in GRAL
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,395,320
New position
Shares Held
35,086
first reported quarter
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 374 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $1,469,656,431 across 16 Diagnostics & Research names. GRAL ranks #16 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
2,367,726 | $314,505,042 | |
| 2 | DHR |
Danaher Corp /De/
|
1,431,212 | $272,617,260 | |
| 3 | LH |
Labcorp Holdings Inc.
|
915,939 | $256,462,920 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
157,559 | $201,283,196 | |
| 5 | ILMN |
Illumina, Inc.
|
1,013,065 | $178,127,218 | |
| 6 | WAT |
Waters Corp /De/
|
171,186 | $64,201,595 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
316,394 | $61,133,647 | |
| 8 | TMO |
Thermo Fisher Scientific Inc.
|
57,375 | $28,765,530 |
All Filings in GRAL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,395,320 | 35,086 | Shares | Defined | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||